Gavin Bowen-Metcalf

Gavin Bowen-Metcalf is a Senior Lecturer in Genetics and Developmental Biology at Anglia Ruskin University (ARU), Cambridge, UK. He holds dual affiliations within the Faculty of Science and Engineering and the Life Sciences department. Gavin is a Fellow of the Higher Education Academy (FHEA) and the Royal Society of Medicine (FRSM), emphasizing his commitment to both academic excellence and clinical relevance.

His educational background includes a joint PhD in Clinical Medicine (Molecular Oncology) and Biomedical Engineering from Imperial College London, an MRes in Oncology and Cancer Biology, and a BSc in Human Biosciences from the University of Northampton. Postdoctoral research at Barts Cancer Institute and NHS clinical experience further underscore his translational research expertise.

Gavin’s research focuses on non-coding RNAs (e.g., microRNAs), natural cancer therapeutics, drug resistance mechanisms, and novel drug target identification. He actively explores the roles of these molecules in cancer development, metastasis, and therapeutic resistance. His work integrates molecular oncology, genomics, and histopathology, with applications in early cancer detection and precision medicine.

As an Associate Editor for Nature Oncogene, External Examiner for the Universities of Birmingham and Nottingham, and Non-Executive Director of the charity Alex TLC, Gavin bridges academic, clinical, and community sectors. His teaching roles include Module Leadership for Principles of Laboratory Science and Human Pathology, reflecting his dual focus on education and research.

Notable achievements include awards for his editorial work and charitable contributions, along with media engagements explaining cancer biology and emerging technologies in The Conversation and The Biologist. Gavin’s interdisciplinary approach combines laboratory science with clinical translation, aiming to advance cancer diagnostics and therapeutics.